(Q33698844)

28 July 2017

1 reference

title

Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods (English)

1 reference

28 July 2017

1 reference

3

N J Talley

1 reference

28 July 2017

S Haag

1

1 reference

PubMed ID

10425418

28 July 2017

S Nandurkar

series ordinal

2

1 reference

PubMed ID

10425418

28 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

Gastrointestinal Endoscopy

28 July 2017

1 reference

28 July 2017

50

1 reference

28 July 2017

2

1 reference

28 July 2017

229-240

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

28 July 2017

1 reference

Barrett's esophagus. Comparison of benign and malignant cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

The diagnosis of Barrett's esophagus: goblets, goblets, goblets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Management of Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Epidemiology of columnar-lined esophagus and adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Incidence of cancer of the esophagus in the US by histologic type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

The increasing frequency of adenocarcinoma of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

The changing incidence of oesophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Incidence trends in oesophageal and proximal gastric carcinoma in Victoria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Rising incidence of oesophageal adenocarcinoma in men in Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978-1992.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Cost effectiveness of detecting Barrett's cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Barrett's esophagus and adenocarcinoma. The need for a consensus conference.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Effect of long-term treatment with cimetidine and antacids in Barrett's oesophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Effects of long-term medical treatment with cimetidine and bethanechol in patients with esophagitis and Barrett's esophagus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Treatment of Barrett's esophagus with H2 blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Gastric acid hypersecretion in refractory gastroesophageal reflux disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Lack of impact of therapy on extent of Barrett's esophagus in 67 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Barrett's ulcer and treatment with cimetidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Long term continuous omeprazole treatment of patients with Barrett's oesophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett's oesophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Barrett's oesophagus: pH profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Role of intragastric and intraoesophageal alkalinisation in the genesis of complications in Barrett's columnar lined lower oesophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Assessment of combined bile acid and pH profiles using an automated sampling device in gastro-oesophageal reflux disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Effect of antireflux operation on Barrett's mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

A new physiologic approach for the surgical treatment of patients with Barrett's esophagus: technical considerations and results in 65 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Surgical therapy in Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Barrett's oesophagus: effect of antireflux surgery on symptom control and development of complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Regression and progression of Barrett's oesophagus after antireflux surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Ablative therapies for the columnar-lined esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Repeat laser therapy of recurrent Barrett's epithelium: success with anacidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Treatment of Barrett's esophagus by endoscopic argon plasma coagulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Reconstitution of squamous epithelium in Barrett's oesophagus with endoscopic argon plasma coagulation: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Laser-induced transient regression of Barrett's epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Regression of Barrett's esophagus by laser ablation in an anacid environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Complete regression of Barrett's esophagus with heat probe thermocoagulation: mid-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Ultrasonic epithelial ablation of the lower esophagus without stricture formation. A new technique for Barrett's ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Photosensitization of malignant tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Photodynamic therapy in gastroenterology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

A centering balloon for photodynamic therapy of esophageal cancer tested in a canine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Endoscopic diagnosis of early carcinoma of the esophagus using Lugol's solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Endoscopic detection of early esophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Chromoendoscopy--where is it useful?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Gastric metaplasia of the duodenum: identification by an endoscopic selective mucosal staining technique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Methylene blue staining for intestinal metaplasia of the gastric cardia with follow-up for dysplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

High-resolution endoluminal sonography is a sensitive modality for the identification of Barrett's metaplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Quantitative endoscopy: precise computerized measurement of metaplastic epithelial surface area in Barrett's esophagus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Extent of Barrett's metaplasia: a prospective study of the serial change in area of Barrett's measured by quantitative endoscopic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Adenocarcinomas arising in tongues or short segments of Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Curable cancer in a short segment Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

Laser photoablation of Barrett's epithelium: burning issues about burning tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

The roles of excessive gastro-oesophageal reflux, disordered oesophageal motility and decreased mucosal sensitivity in the pathogenesis of Barrett's oesophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Regression of Barrett's epithelium with omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970230-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0016-5107(99)70230-0

1 reference

28 July 2017

1 reference

PubMed ID

10425418